We confirmed that relative to those with LGR5+ and KRASmut status, LGR5−/KRASwt colon carcinomas had decreased CDH1 and increased VIM and SLUG expressions, which are the expected changes in EMT biomarkers (Figure 6J). The gene discussed is CDH1; the disease is colon carcinoma.